Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and the Emerging Role of Resmetirom: A Comprehensive Review. JIMC [Internet]. 2025 Dec. 2 [cited 2026 Feb. 3];8(1). Available from: https://jimc.org.pk/index.php/jimc/article/view/75